Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Volume: 383, Issue: 21, Pages: 2041 - 2052
Published: Nov 19, 2020
Abstract
Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited.We conducted a multicenter, randomized, open-label, three-group, controlled trial involving hospitalized patients with suspected or confirmed Covid-19 who were receiving either no supplemental oxygen or a maximum of 4 liters per minute of supplemental oxygen....
Paper Details
Title
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Published Date
Nov 19, 2020
Volume
383
Issue
21
Pages
2041 - 2052
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.